← Leaderboards
Stewart Donaldson Clark
University Of California-Irvine
$6,657,200
Attributed
$8,483,194
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2009–24$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,483,194 · 9
By mechanism
R01$2,895,212 · 2
R56$1,903,454 · 2
RF1$1,808,406 · 1
R21$858,501 · 2
R00$775,487 · 1
K99$242,134 · 1
Top collaborators
- Scott P Runyon6 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Jun Allard$1,738,125
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBehaviorBehavioralNeuropeptidesPathway InteractionsEventBrainReceptorSymptomsFutureBaseStructureNeuronsCollaborationsMediatingLearningAddictionLigandsAcuteAgonistIn VitroIn VivoDopaminergic NeuronMolecular
Grant awards (18)
Tau accumulation in the pedunculopontine tegmentum as an early node in Progressive Supranuclear Palsy pathogenesis$594,588
R01 · FY2024 · NS · contact PI
Preclinical Trial: Targeting the Neuropeptide S Receptor to Curb Opioid Taking and Seeking$419,876
R21 · FY2024 · DA · contact PI
Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor$730,330
R01 · FY2022 · MH
Tau accumulation in the pedunculopontine tegmentum as an early node in Progressive Supranuclear Palsy pathogenesis$1,808,406
RF1 · FY2021 · NS · contact PI
Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor$793,020
R01 · FY2021 · MH
Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor$732,737
R01 · FY2020 · MH
Tau accumulation in the pedunculopontine tegmentum as an early node in Progressive Supranuclear Palsy pathogenesis$552,090
R56 · FY2020 · NS · contact PI
Dissecting the Paradox of the Neuropeptide S System$199,375
R21 · FY2020 · DA · contact PI
Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor$44,537
R01 · FY2020 · MH
Dissecting the Paradox of the Neuropeptide S System$239,250
R21 · FY2019 · DA · contact PI
Small molecule biased agonists of the NPS receptor$661,737
R56 · FY2018 · MH
Small molecule biased agonists of the NPS receptor$689,627
R56 · FY2017 · MH
Modulation of Dopaminergic VTA Neurons by Urotensin II$239,040
R00 · FY2013 · DA · contact PI
Modulation of Dopaminergic VTA Neurons by Urotensin II$38,445
R00 · FY2013 · DA · contact PI
Modulation of Dopaminergic VTA Neurons by Urotensin II$249,001
R00 · FY2012 · DA · contact PI
Modulation of Dopaminergic VTA Neurons by Urotensin II$249,001
R00 · FY2011 · DA · contact PI
Modulation of Dopaminergic VTA Neurons by Urotensin II$131,582
K99 · FY2010 · DA · contact PI
Modulation of Dopaminergic VTA Neurons by Urotensin II$110,552
K99 · FY2009 · DA · contact PI